(40) reported that the CD109 expression was negatively associated with tumor stage and pathological grade via inhibiting TGF-β/Smad signaling in BLCA, which was corresponded with the results of GSEA and RNA-sequence in our center. This evidence concerns the gene CD109 and bladder transitional cell carcinoma.